Manuel Neuberger
Overview
Explore the profile of Manuel Neuberger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kowalewski K, Neuberger M, Sidoti Abate M, Kirchner M, Haney C, Siegel F, et al.
Eur Urol Oncol
. 2023 Jun;
7(1):91-97.
PMID: 37316398
Background: There is no evidence from randomized controlled trials (RCTs) comparing robot-assisted partial nephrectomy (RAPN) and open partial nephrectomy (OPN). Objective: To assess the feasibility of trial recruitment and to...
12.
Hartung F, Kowalewski K, Morina F, Egen L, Neuberger M, Gruene B, et al.
Urol Int
. 2023 Jun;
107(7):678-683.
PMID: 37307804
Introduction: The aim of this study was to investigate and compare clinical safety and efficiency of Thulium laser enucleation of the prostate (ThuLEP) and robot-assisted simple prostatectomy (RASP) for the...
13.
Derigs F, Kowalewski K, Hartung F, Waldbillig F, Neuberger M, von Hardenberg J, et al.
Urology
. 2023 Apr;
177:128-133.
PMID: 37019390
Objective: To compare software-based three-dimensional-guided systematic prostate biopsy (3D-GSB) with conventional transrectal ultrasound-guided systematic biopsy (TGSB) regarding prostate cancer (PCa) detection rates (CDR). Methods: In total, 956 patients (200 TGSB...
14.
Waldbillig F, Bormann F, Neuberger M, Ellinger J, Erben P, Kriegmair M, et al.
Diagnostics (Basel)
. 2023 Mar;
13(5).
PMID: 36899967
To date, only a single transcriptome-wide m6A sequencing study of clear cell renal cell carcinoma (ccRCC) has been reported, with no validation so far. Herein, by TCGA analysis of the...
15.
Grune B, Kowalewski K, Weiss C, Neuberger M, Nientiedt M, Wenk M, et al.
Urol Int
. 2023 Feb;
107(6):583-590.
PMID: 36812902
Introduction: First external validation of the Bladder Complexity Score (BCS) for predicting complex transurethral resection of bladder tumours (TURBT). Methods: For BCS calculation, TURBTs performed at our institution between January...
16.
Integrin Expression in Localized Prostate Cancer: A TCGA and MSKCC Cohort-based Exploratory Analysis
Neuberger M, Frey L, Nitschke K, Wessels F, Westhoff N, Waldbillig F, et al.
Anticancer Res
. 2022 Dec;
43(1):417-428.
PMID: 36585191
Background/aim: Diagnostic and prognostic biomarkers in localized prostate cancer (PC) are insufficient. Treatment stratification relies on prostate-specific antigen, clinical tumor staging and International Society of Urological Pathology (ISUP) grading, whereas...
17.
Neuberger M, Weiss C, Goly N, Skladny J, Nitschke K, Wessels F, et al.
Discov Oncol
. 2022 Dec;
13(1):140.
PMID: 36522513
Objectives: To assess the predictive and prognostic value of changes in longitudinal neutrophile-to-lymphocyte (NLR) ratios in men receiving taxane-based chemotherapy for metastatic prostate cancer (PC). Methods: Retrospective, unicentric cohort study...
18.
Perioperative Antibiotic Prophylaxis in Radical Prostatectomy: "Single-Shot" versus Multiday Regimen
Hartung F, Herrmann J, Kowalewski K, Neuberger M, Weiss C, Kriegmair M, et al.
Urol Int
. 2022 Dec;
107(5):447-453.
PMID: 36516804
Introduction: Perioperative antibiotic prophylaxis (AP) is common in radical prostatectomy (RP). Yet there is no standard recommendation in international guidelines due to poor evidence. It is of great importance that...
19.
Waldbillig F, von Rohr L, Nientiedt M, Neuberger M, Wessels F, V Hardenberg J, et al.
Urol Int
. 2022 Dec;
107(2):179-185.
PMID: 36481539
Introduction: The aim of this randomised prospective trial was to evaluate a novel hands-on endourological training programme (HTP) and compare it to the standard endourological colloquium (SC). Methods: A new...
20.
Westhoff N, Ernst R, Kowalewski K, Derigs F, Neuberger M, Norenberg D, et al.
Eur Urol Focus
. 2022 Nov;
9(2):283-290.
PMID: 36344395
Background: Multiparametric magnetic resonance imaging (mpMRI)/transrectal ultrasound (TRUS) fusion-guided high-intensity focused ultrasound (HIFU) is a focal treatment option for MRI-visible localized prostate cancer (PCa). High-quality evidence regarding the clinical efficacy...